BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31625429)

  • 1. CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases.
    Garcia-Robledo JE; Barrera MC; Tobón GJ
    Int Rev Immunol; 2020; 39(1):11-20. PubMed ID: 31625429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity, evolution, and therapeutic applications of small RNAs in prokaryotic and eukaryotic immune systems.
    Cooper EL; Overstreet N
    Phys Life Rev; 2014 Mar; 11(1):113-34. PubMed ID: 24286719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials.
    Kick L; Kirchner M; Schneider S
    Bioengineered; 2017 May; 8(3):280-286. PubMed ID: 28287876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas systems: beyond adaptive immunity.
    Westra ER; Buckling A; Fineran PC
    Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.
    Westra ER; van Houte S; Gandon S; Whitaker R
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20190101. PubMed ID: 30905294
    [No Abstract]   [Full Text] [Related]  

  • 9. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.
    Mohanraju P; Makarova KS; Zetsche B; Zhang F; Koonin EV; van der Oost J
    Science; 2016 Aug; 353(6299):aad5147. PubMed ID: 27493190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decade of discovery: CRISPR functions and applications.
    Barrangou R; Horvath P
    Nat Microbiol; 2017 Jun; 2():17092. PubMed ID: 28581505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origins and evolution of CRISPR-Cas systems.
    Koonin EV; Makarova KS
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180087. PubMed ID: 30905284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prokaryote autoimmunity in the context of self-targeting by CRISPR-Cas systems.
    Lenskaia T; Boley D
    J Bioinform Comput Biol; 2020 Oct; 18(5):2050033. PubMed ID: 33078994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
    Faure G; Makarova KS; Koonin EV
    J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanzor is a eukaryotic programmable RNA-guided endonuclease.
    Saito M; Xu P; Faure G; Maguire S; Kannan S; Altae-Tran H; Vo S; Desimone A; Macrae RK; Zhang F
    Nature; 2023 Aug; 620(7974):660-668. PubMed ID: 37380027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering.
    Kirchner M; Schneider S
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13508-14. PubMed ID: 26382836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of CRISPR-Cas systems in adaptive immunity and beyond.
    Barrangou R
    Curr Opin Immunol; 2015 Feb; 32():36-41. PubMed ID: 25574773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.
    Wright AV; Nuñez JK; Doudna JA
    Cell; 2016 Jan; 164(1-2):29-44. PubMed ID: 26771484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adapting to new threats: the generation of memory by CRISPR-Cas immune systems.
    Heler R; Marraffini LA; Bikard D
    Mol Microbiol; 2014 Jul; 93(1):1-9. PubMed ID: 24806524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SnapShot: CRISPR-RNA-guided adaptive immune systems.
    Carter J; Wiedenheft B
    Cell; 2015 Sep; 163(1):260-260.e1. PubMed ID: 26406380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.